Phoenix Pharmahandel GmbH & Co KG - Company Profile & SWOT Analysis

Phoenix Pharmahandel GmbH & Co KG - Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Phoenix Pharmahandel GmbH & Co KG (Phoenix Group) is a pharmaceutical trading company which offers integrated supply chain solutions for pharmaceutical companies. It undertakes wholesale distribution of both prescription and non-prescription pharmaceuticals. The company directly supplies pharmaceuticals and health products to general public and offers professional advisory services at retail outlets. Phoenix Group distributes health products and drugs of various pharmaceutical manufacturers to pharmacies and medical institutions. It offers business intelligence products and services that enable pharmaceutical manufacturers to focus on the development and production of superior drugs. The company operations are spread across Albania, Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Hungary, Italy, Kosovo, Serbia, the UK, Norway, Poland, Sweden, Lithuania, Macedonia, Switzerland, the Netherlands, and Latvia. Phoenix Group is headquartered in Mannheim, Germany.

Scope

  • Detailed information on Phoenix Pharmahandel GmbH & Co KG required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Phoenix Pharmahandel GmbH & Co KG in the form of a SWOT analysis
  • An in-depth view of the business model of Phoenix Pharmahandel GmbH & Co KG including a breakdown and examination of key business segments
  • News about Phoenix Pharmahandel GmbH & Co KG, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Phoenix Pharmahandel GmbH & Co KG and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Phoenix Pharmahandel GmbH & Co KG as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Phoenix Pharmahandel GmbH & Co KGs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Denk Pharma GmbH & Co KG

Hoechst GmbH

K.U. Leuven Research & Development

Denk Pharma GmbH & Co KG

Hoechst GmbH

K.U. Leuven Research & Development

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

Section 1 - About the Company 5

Phoenix Pharmahandel GmbH & Co KG - ...

Table of Contents

Table of Contents 3

List of Tables 4

Section 1 - About the Company 5

Phoenix Pharmahandel GmbH & Co KG - Key Facts 5

Phoenix Pharmahandel GmbH & Co KG - Key Employees 6

Phoenix Pharmahandel GmbH & Co KG - Major Products and Services 7

Phoenix Pharmahandel GmbH & Co KG - History 8

Phoenix Pharmahandel GmbH & Co KG - Locations And Subsidiaries 9

Head Office 9

Other Locations & Subsidiaries 9

Section 2 – Company Analysis 11

Company Overview 11

Phoenix Pharmahandel GmbH & Co KG - Business Description 12

Phoenix Pharmahandel GmbH & Co KG - SWOT Analysis 13

SWOT Analysis - Overview 13

Phoenix Pharmahandel GmbH & Co KG - Strengths 13

Phoenix Pharmahandel GmbH & Co KG - Weaknesses 14

Phoenix Pharmahandel GmbH & Co KG - Opportunities 15

Phoenix Pharmahandel GmbH & Co KG - Threats 16

Phoenix Pharmahandel GmbH & Co KG - Key Competitors 17

Phoenix Pharmahandel GmbH & Co KG, Recent Deals Summary 18

Section 3 – Company’s Recent Developments 19

Nov 08, 2018: Phoenix Nest Inc. Licenses a Sanfilippo Syndrome Gene Therapy From the University of Manchester and is Preparing for a Clinical Trial 19

Nov 08, 2018: Phoenix Nest Inc. Licenses a Sanfilippo Syndrome Gene Therapy From the University of Manchester and is Preparing for a Clinical Trial 22

Nov 07, 2018: Phoenix Nest Inc., Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and Washington University in St. Louis Announce a New NIH Grant for Sanfilippo Syndrome (MPSIIID) 25

Nov 07, 2018: Phoenix Nest Inc., Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and Washington University in St. Louis Announce a New NIH Grant for Sanfilippo Syndrome (MPSIIID) 27

Nov 07, 2018: Phoenix Nest Inc., Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and Washington University in St. Louis Announce a New NIH Grant for Sanfilippo Syndrome (MPSIIID) 29

Nov 07, 2018: Phoenix Nest Inc., Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and Washington University in St. Louis Announce a New NIH Grant for Sanfilippo Syndrome (MPSIIID) 31

Nov 07, 2018: Phoenix Nest Inc., Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and Washington University in St. Louis Announce a New NIH Grant for Sanfilippo Syndrome (MPSIIID) 33

Nov 02, 2018: Phoenix Business Journal Names GlobalTranz s General Counsel Jeff Simmons as Finalist for General Counsel of the Year 35

Nov 02, 2018: Phoenix Business Journal Names GlobalTranz s General Counsel Jeff Simmons as Finalist for General Counsel of the Year 37

Nov 02, 2018: Phoenix Business Journal Names GlobalTranz s General Counsel Jeff Simmons as Finalist for General Counsel of the Year 39

Section 4 – Appendix 41

Methodology 41

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Tables

List of Tables

Phoenix Pharmahandel GmbH & Co KG, Key Facts 5

Phoenix Pharmahandel GmbH & Co KG, Key Employees 6

Phoenix Pharmahandel GmbH & ...

List of Tables

Phoenix Pharmahandel GmbH & Co KG, Key Facts 5

Phoenix Pharmahandel GmbH & Co KG, Key Employees 6

Phoenix Pharmahandel GmbH & Co KG, Major Products and Services 7

Phoenix Pharmahandel GmbH & Co KG, History 8

Phoenix Pharmahandel GmbH & Co KG, Subsidiaries 9

Phoenix Pharmahandel GmbH & Co KG, Key Competitors 17

Phoenix Pharmahandel GmbH & Co KG, Recent Deals Summary 18

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports